News
Publications
Multimedia
Conferences
Webcasts
Resources
Event Calendar
Subscribe

Spotlight -

Drug Development|

Quality Systems

|Articles|October 11, 2007

FMEA tool

Author(s)Keith Truman, Phil Nethercote, Phil Borman

This downloadable Failure Mode Effect Analysis tool accompanies the article titled 'The Application of Quality by Design to Analytical Methods' by Phil Borman et. al.

External Link - article-464686.xls

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

Brian Drapeau

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

ByBrian Drapeau

July 16th 2026

Topical Corticosteroid Bioequivalence Guidance Ends 30-Year Wait

The Implications of the FDA’s New Finalized Guidance Documents

ByZachary Zubulake

July 16th 2026

FDA concept. Concept of the Food and Drug Administration. Magnifier glass, folder and clock | Image credit: © Sviatlana - © Sviatlana-stock.adobe.com

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

ByFeliza Mirasol,Jeffrey C. Mocny,Anna McMahon

July 15th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

FDA Activity Round Up – July 2026

ByZachary Zubulake

July 15th 2026

test tube ampoule syringe flag europe doctor vaccine medicine | Image Credit: ©NataliAlba -stock.adobe.com

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

BySusan Haigney

July 15th 2026

Trending on Pharmaceutical Technology

FDA Activity Round Up – July 2026

Using Automation to Enhance Pharmaceutical Manufacturing

Hidden Cost Drivers in Oligonucleotide Manufacturing

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development